Spectrum Pharmaceuticals, Inc. Shareholder Alert: Kaplan Fox Investigates Potential Securities Fraud
03 nov. 2022 17h16 HE
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors in Spectrum Pharmaceuticals, Inc. (“Spectrum” or the...
Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) Investor Alert: Kaplan Fox Investigates Potential Securities Fraud
28 oct. 2022 14h41 HE
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Oct. 28, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors in Spectrum Pharmaceuticals, Inc. (“Spectrum” or the...
Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI) Investor Alert: Kaplan Fox Investigates Potential Securities Fraud
23 sept. 2022 16h21 HE
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Sept. 23, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors in Spectrum Pharmaceuticals, Inc. (“Spectrum” or the...